GamaMabs Pharma to present new data at AACR 2018
Antibiotic resistance: Nosopharm and the University of Illinois at Chicago in Molecular Cell
Genoscience Pharma starts first-in-human dosing of GNS561 in patients with advanced liver cancer
Domain’s business model gains validation through Prexton’s acquisition by Lundbeck for up to $1.1 billion
Lundbeck to acquire Prexton Therapeutics in a deal valued at up to €905 million
BCI Pharma receives €3.9M ($4.7M) in public and private funding; sets up laboratory
Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor bioSens-All™ technology
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics
